Skip to main content
. 2017 Oct-Dec;9(4):74–83.

Table 2.

Distribution of alleles and genotypes of polymorphic regions of the examined genes in MI patients (n = 405) and controls (n = 198)

Carriage of alleles
and genotypes
Patients,
n (%)
Controls,
n (%)
p pcorr** OR (95% CI) for significant
differences**
rs562556 in PCSK9
A 389(96) 193(97) NS NS  
G 102(25) 65(33) 0.013 NS 0.69 (0.47–1.00)
A/A 303(75) 133(67) 0.013 NS 1.45 (1.00–2.10)
A/G 86(21) 60(30) 0.010 NS 0.62 (0.42–0.91)
G/G 16(4) 5(3) NS NS  
rs7412, rs429358 (epsilon polymorphism) in APOE
ε2 63(16) 30(15) NS NS  
ε3 393(98) 194(98) NS NS  
ε4 40(10) 38(19) 0.0013 0.0091 0.46 (0.28–0.75)
ε2/ε2 5(1) 2(1) NS NS  
ε2/ε3 55(14) 26(13) NS NS  
ε2/ε4 3(1) 2(1) NS NS  
ε3/ε3 305(75) 132(67) 0.017 NS 1.52 (1.05–2.2)
ε3/ε4 33(8) 36(18) 0.00033 0.0023 0.40 (0.24–0.66)
ε4/ε4 4(1) 0(0)      
rs320 in LPL
G 192(47) 85(43) NS NS  
T 363(90) 187(94) 0.032 NS 0.51 (0.25–0.99)
G/G 42(10) 11(6) 0.032 NS 0.51 (0.25–0.99)
G/T 150(37) 74(37) NS NS  
T/T 213(53) 113(57) NS NS  
rs1801133 in MTHFR
C 369(91) 174(87) NS NS  
G 206(51) 106(54) NS NS  
C/C 199(49) 92(46) NS NS  
C/T 170(42) 82(41) NS NS  
T/T 36(9) 24(13) NS NS  
rs2070744 in eNOS
C 253(62) 100(50) 0.0034 0.024 1.63 (1.16–2.30)
T 343(85) 174(88) NS NS  
C/C 62(15) 24(12) NS NS  
C/T 191(47) 76(38) NS NS  
T/T 152(38) 98(50) 0.0034 0.024 0.61 (0.43–0.86)
rs1333049 in the 9p21 region
C 313(78) 155(78) NS NS  
G 305(75) 146(74) NS NS  
C/C 100(25) 52(26) NS NS  
C/G 213(53) 103(52) NS NS  
G/G 92(22) 43(22) NS NS  

NS – not significant.

*The Bonferroni correction for the number of tests (multiple comparisons) was applied to the p values.

**p < 0.05.